News LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
62.62 ^USD	-0.67%		-4.63%	+10.32%

Mar. 12	Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing	MT
Mar. 07	Lemaitre Vascular Insider Sold Shares Worth $344,925, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LeMaitre Vascular : Proxy Statement for 2024 Annual Meeting	Apr. 16	PU
LeMaitre Vascular : Proxy Card for 2024 Annual Meeting	Apr. 16	PU
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference	Mar. 26	AQ
Ex-dividend day	Mar. 12	FA
Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing	Mar. 12	MT
Lemaitre Vascular Insider Sold Shares Worth $344,925, According to a Recent SEC Filing	Mar. 07	MT
Lemaitre Vascular Insider Sold Shares Worth $517,500, According to a Recent SEC Filing	Mar. 07	MT
LeMaitre to Participate at Upcoming Investor Conferences in March	Mar. 01	AQ
Health Care Drops After Mixed Earnings -- Health Care Roundup	Feb. 28	DJ
Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	Feb. 28	MT
LeMaitre: Q4 Earnings Snapshot	Feb. 27	AQ
LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on March 28, 2024	Feb. 27	CI
LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	Feb. 27	CI
LeMaitre Vascular, Inc. announces an Equity Buyback for $50 million worth of its shares.	Feb. 27	CI
LeMaitre Vascular, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Transcript : LeMaitre Vascular, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
(LMAT) LEMAITRE VASCULAR Forecasts Fiscal Year 2024 EPS $1.65	Feb. 27	MT
(LMAT) LEMAITRE VASCULAR Expects Q1 EPS $0.28	Feb. 27	MT
Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q4 Revenue $48.9M, vs. Street Est of $49M	Feb. 27	MT
LeMaitre Q4 2023 Financial Results	Feb. 27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Summary

Filters